PATENT CLAIM ANALYSIS

Application Number: 16468658
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["514", "249000"]

Abstract:
The present invention provides a compound having a structure shown in formula (I) or an isomer, pharmaceutically acceptable solvate, or salt thereof. The compound is used as a Bruton's tyrosine kinase inhibitor, and has a higher inhibitory activity against BTK and less adverse effects.

Claim (Index 20):
The method according to  claim 19 , wherein the BTK-mediated disease is selected from the group consisting of immune, autoimmune, inflammatory diseases, allergies, infectious diseases, proliferative conditions and cancerous diseases and combinations thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.2381
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16191190', '15969864', '15762367', '14228184', '13436963']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.804967098655412
- 35 USC 102 Novelty (BERT): 0.5199326408467472
- Combined Prediction Score: 0.7764636528745457
- Mean Citation Score: 288.591296
- Max Citation Score: 311.26706
- Similarity Product: 202.3289990438772

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test